Related Experiment Videos
Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children
Insights
Carbamazepine in epileptic children prolonged auditory pathway responses, while valproate showed no consistent effects on brainstem auditory evoked potentials (BAEPs). This suggests carbamazepine may suppress auditory function.
Area of Science:
- Neuroscience
- Clinical Pharmacology
- Audiology
Background:
- Epilepsy affects auditory processing.
- Antiepileptic drugs (AEDs) can have neurological side effects.
- Brainstem auditory evoked potentials (BAEPs) assess auditory pathway function.
Purpose of the Study:
- To investigate the effects of carbamazepine and valproate on auditory pathway function in epileptic children.
- To compare the neurophysiological impact of two common AEDs on BAEPs.
Main Methods:
- BAEPs were recorded in 18 children on carbamazepine and 10 on valproate.
- Recordings were taken before and after 13 months of AED treatment.
- Analysis focused on peak latencies and interpeak intervals of waves I-III-V.
Main Results:
- Carbamazepine treatment significantly prolonged peak latencies (I-III-V) and interpeak intervals (I-III, I-V).
- Valproate monotherapy did not produce consistent changes in BAEP parameters.
- These findings indicate a suppressive effect of carbamazepine on the auditory system.
Conclusions:
- Chronic carbamazepine therapy may negatively impact auditory pathways.
- The effects of carbamazepine appear to involve both peripheral and central auditory structures.
- Valproate showed a neutral effect on auditory pathway function in this cohort.
Abstract:
Brainstem auditory evoked potentials (BAEPs) were recorded in 18 epileptic children receiving carbamazepine and 10 epileptic children receiving valproate. BAEPs were recorded before the administration of antiepileptic drugs (AEDs) and 13 months later during which the children received AEDs. Statistical analysis of peak latencies and interpeak intervals of waves I-III-V were made. Carbamazepine treatment resulted in prolongation of peak latencies of waves I-III-V and interpeak intervals I-III and I-V. Valproate monotherapy, on the other hand, caused no consistent changes on BAEP. On the basis of these results we suggest that chronic carbamazepine therapy exerts a suppressive influence on the auditory pathways, both peripherally at the level of the cochlea and/or auditory nerve, and centrally at the brainstem.